Related Experiment Video

Updated: May 20, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Is nonalcoholic fatty liver disease in children the same disease as in adults?

Evelyn Hsu1, Karen Murray

  • 1Division of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, WA 98115, USA. evelyn.hsu@seattlechildrens.org

Clinics in Liver Disease
|July 25, 2012
PubMed

Insights

Nonalcoholic fatty liver disease (NAFLD) is a growing concern in children, affecting various demographics. Current diagnostic and treatment strategies for pediatric NAFLD require further investigation and validation.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Liver Disease Research

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the primary driver of chronic liver disease among pediatric populations.
  • NAFLD incidence exhibits variations across different racial and gender groups in children.
  • The condition can manifest even in early childhood, including toddlerhood.

Purpose of the Study:

  • To summarize the current understanding of pediatric nonalcoholic fatty liver disease.
  • To highlight diagnostic challenges and the limitations of current treatment approaches in children.
  • To underscore the need for further research into noninvasive diagnostic tools and effective pediatric NAFLD therapies.

Main Methods:

  • Review of existing literature on pediatric nonalcoholic fatty liver disease.
  • Analysis of epidemiological data regarding NAFLD prevalence in children.
  • Evaluation of current diagnostic standards and therapeutic interventions for pediatric NAFLD.

Main Results:

  • Liver biopsy remains the definitive method for diagnosing and staging pediatric NAFLD.
  • Noninvasive diagnostic methods for pediatric NAFLD are under active investigation.
  • Established adult NAFLD treatments, like insulin sensitizers and Vitamin E, lack definitive efficacy in children.

Conclusions:

  • Pediatric NAFLD is a significant health issue with complex diagnostic and therapeutic considerations.
  • Further research is crucial for developing reliable noninvasive diagnostic tools for children.
  • Tailored and validated treatment strategies are needed for effective management of NAFLD in pediatric patients.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...